l-carnitine and tmao γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to Frontiers | The gut microbial
Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases TMAO Is Both a Biomarker and a Renal Toxin Circulation Research Frontiers Effect of a polyphenol rich pomegranate extract on plasma trimethylamine N oxide levels following an oral carnitine challenge: a randomized controlled crossover trial in healthy adults Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target
Pay in 4 interest-free payments of $6.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



